Like ImageIQ

closed 5/24/2017 via BNC Analysis

ERT, acquired ImageIQ

synopsis: ERT - a provider of clinical trial services - announced the acquisition of ImageIQ, an imaging software and contract research organization and software developer for customized imaging and analysis.
buyer parent: Nordic Capital
buyer: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions. "
target: ImageIQ
ImageIQ is an imaging software and contract research organization and software developer for customized imaging and analysis.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$8,793.96)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
announced 9/30/2020 via BNC Analysis

Comet Group, will acquire Object Research Systems, Inc.

synopsis: The Comet Group, a globally leading Swiss technology firm, will acquire Object Research Systems (ORS), a provider of 3D-visualization and analysis solutions for research and industrial applications in Canada. ORS' Dragonfly platform delivers volume rendering and advanced analysis functions. They also offer a powerful medical imaging solution.
buyer: Comet Group (SWX:COTN:$412.18)
The Comet Group is a globally leading Swiss technology firm. Comet develops and produces innovative high-tech components and systems based on x-ray and radio frequency (RF). The group manufactures RF matching networks, RF generators, x-ray modules, x-ray tubes, x-ray systems, and more. "
target: Object Research Systems, Inc.
Object Research Systems (ORS) is a provider of 3D-visualization and analysis solutions for research and industrial applications in Canada. ORS' Dragonfly platform delivers state-of-the-art volume rendering and advanced analysis functions. They also offer a powerful medical imaging solution.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/27/2019 via Company Press Release

Canon Medical System, will acquire Skope Magnetic Resonance Technologies AG

synopsis: Canon Medical Systems, a Japanese subsidiary of Canon that developed and introduced the first Japanese MRI and has been devoting itself to research and development of innovative MRI technologies, has acquired Skope, a Swiss company devoted to providing MRI users with unprecedented imaging quality and performance.
buyer parent: Canon Inc.
buyer: Canon Medical System
Canon Medical Systems developed and introduced the first Japanese MRI in 1983, and has been devoting itself to research and development of innovative MRI technologies such as Pianissimo, Canon Medical’s unique acoustic noise reduction technology, providing extraordinary patient comfort. "
target: Skope Magnetic Resonance Technologies AG
Skope Magnetic Resonance Technologies AG is a Swiss company devoted to providing MRI users with unprecedented imaging quality and performance. Skope’s expertise in MRI sensorics, signal-processing and image reconstruction covers the entire chain from signal acquisition to image generation
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/14/2018 via BNC Analysis

Flying Brands LTD., acquired Imaging Biometrics

synopsis: Flying Brands, a medical services and software company based in the United Kingdom, has acquired Imaging Biometrics, a company based in Wisconsin that is advancing the field of medical imaging by specializing in the design and manufacture of advanced visualization software solutions using quantitative imaging endpoints/biomarkers.
buyer: Flying Brands LTD.
Flying Brands Limited is a medical services and software company based in the United Kingdom. Their product, Stonechecker, is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention. "
target: Imaging Biometrics
Imaging Biometrics (IB) is based in Wisconsin, USA. It is advancing the field of medical imaging by specializing in the design and manufacture of advanced visualization software solutions using quantitative imaging endpoints/biomarkers.
price ($mm)
$0.76
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2016 via PR Newswire

Zimmer Biomet Holdings, Inc., acquired Clinical Graphics, B.V.

synopsis: Zimmer Biomet Holdings, Inc. announced the strategic acquisition of Clinical Graphics, B.V., a novel imaging company specializing in 3D range-of-motion simulation technology to inform treatment decisions for hip conditions requiring early intervention. Zimmer Biomet plans to integrate the imaging platform to enhance its hip preservation portfolio.
buyer: Zimmer Biomet Holdings, Inc. (ZBH:$7,604.40)
Zimmer Biomet is a global leader in musculoskeletal healthcare. They design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products, bone healing, dental implants; and related surgical products. "
target: Clinical Graphics, B.V.
Clinical Graphics began in 2010 as a spin-off from Delft University of Technology and is headquartered in The Netherlands at technology incubator Yes!Delft. The company enables physicians to see beyond the usual by converting medical scans into 3D motion simulations of patients' anatomy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/4/2016 via BusinessWire

Sectra AB, acquired RxEye AB

synopsis: IT and medical technology company Sectra has acquired the Swedish company RxEye AB, which sells cloud-based IT services for efficient and secure remote viewing of medical images.
buyer: Sectra AB (STO:SECTB:$121.11)
Sectra successfully develops and sells cutting edge solutions and services within the niches medical IT and secure communication. The company’s products are used by customers in 50 countries and sales are conducted directly by Sectra as well as through regional partners. "
target: RxEye AB
RxEye AB sells cloud-based IT services for efficient and secure remote viewing of medical images. The services are used, for example, by radiology, nuclear medicine and pathology departments, as well as by companies that sell teleradiology services.
price ($mm)
rev ($mm)
$1
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 7/16/2012 via PR Newswire

Accuray Incorporated, will acquire Morphormics, Inc.

synopsis: Accuray Incorporated, the premier radiation oncology company, announced that they have signed a definitive agreement to acquire Morphormics, Inc., a privately held company founded by University of North Carolina at Chapel Hill faculty members based on their research in autosegmentation of medical images.
buyer: Accuray Incorporated (ARAY:$409.22)
Accuray Incorporated, based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized innovative treatment solutions that set the standard of care, with the aim of helping patients live longer, better lives. "
target: Morphormics, Inc.
Morphormics, Inc. develops medical imaging software systems that dramatically increase efficiency and success in image-guided medical treatment planning, intervention, and diagnosis. Their image analysis automatically recognizes and extract anatomical structures from 2D, 3D and 4D medical images.
price ($mm)
$4.80*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/25/2016 via Company Press Release

Vela Diagnostics Pte. Ltd., purchased Data Interpretation Division from Lifecode, Inc.

synopsis: Vela Diagnostics announced that it has acquired the data interpretation division of Lifecode Inc., a Foster City, California-based cancer molecular company. The data interpretation products and services from Lifecode will be connected to Vela Diagnostics’ Next-Generation Sequencing Sentosa® SQ Reporter Software.
buyer: Vela Diagnostics Pte. Ltd.
Vela Diagnostics is a worldwide supplier of integrated life sciences and diagnostic solutions that help provide customers with valuable molecular information. It delivers innovative technology and products* that address many of the clinical, technical and economic issues facing laboratories. "
seller: Lifecode, Inc.
Lifecode Inc’s data interpretation service provides access to Lifecode’s data integration framework, interpretation and report generation pipelines. Lifecode is a specialized CLIA certified clinical laboratory focused on the genetic basis of human disease.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/11/2016 via BNC Analysis

Stryker Corporation, acquired imorphics

synopsis: Stryker Corporation has acquired Imorphics, Ltd. Imorphics was initially a spin out from the world renowned Computer Imaging Department of Manchester University. Its product, EndPoint, is a software environment in which the user can build and use statistical models, as well as view images and perform analysis tasks, such as manual segmentation.
buyer: Stryker Corporation (SYK:$10,062.00)
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. "
target: imorphics
Imorphics, Ltd. provides medical image analysis software tools. Its projects include work on diseases of the musculoskeletal system, the central nervous system, and oncology. The company’s technology is used in clinical trials, and in both clinical and animal research projects.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/10/2012 via PR Newswire

Telemis, acquired Telemis

synopsis: Nivelinvest and Sopartec announced the disposal of their majority stake in Telemis in a management buyout. Telemis' solutions allow healthcare institutions to manage their medical imaging in order to improve the quality of their services.
buyer: Telemis
Telemis is specialized in the development of medical imaging software, more specifically of PACS software. Telemis' products are designed to help hospitals, clinics and private practices manage medical imaging and eliminate X-Ray films in order to reduce costs and improve medical healthcare quality."
target parent: Sopartec
target: Telemis
Telemis is specialized in the development of medical imaging software, more specifically of PACS software. Telemis' products are designed to help hospitals, clinics and private practices manage medical imaging and eliminate X-Ray films in order to reduce costs and improve medical healthcare quality.
price ($mm)
rev ($mm)
$10
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 7/17/2012 via PR Newswire

Shenzhen Institutes of Advanced Technology, will purchase WebPAX from Heart IT

synopsis: Heart IT, the global leader that pioneered the first FDA approved zero footprint medical imaging workstation announced that the Shenzhen Institutes of Advanced Technology, a branch of the Chinese Academy of Science (CAS), has elected to acquire WebPAX® in order to receive and share medical images across multiple hospitals.
buyer parent: Chinese Academy of Science
buyer: Shenzhen Institutes of Advanced Technology
Shenzhen Institutes of Advanced Technology SISIAT is an innovative national research institute committed to medical research, internationalization and industrialization. SIAT engages in comprehensive and multi-disciplinary researches in several divisions. "
seller: Heart IT
Founded in 2000 and headquartered near North Carolina's Research Triangle Park, Heart IT is a global leader in the medical image web enablement field. Their flagship product, WebPAX® is the first FDA approved zero footprint medical image workstation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2012 via PR Web

Visualization Sciences Group, acquired Amira

synopsis: Visage Imaging, Inc. announced they have signed a definitive agreement completing the sale of the Amira Division to Visualization Sciences Group. Amira is a powerful, multifaceted software platform for visualizing, manipulating, and understanding Life Science and bio-medical data coming from all types of sources and modalities.
buyer parent: FEI
buyer: Visualization Sciences Group
Visualization Sciences Group is the leading provider of high-performance 3D visualization toolkits and software for engineers and scientists, delivering advanced 3D software solutions for scientific data visualization, engineering and simulation, materials science and geosciences. "
target parent: Pro Medicus
target: Amira
Amira is a powerful, multifaceted software platform for visualizing, manipulating, and understanding Life Science and bio-medical data coming from all types of sources and modalities.
price ($mm)
$15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2020 via BusinessWire

Riverside Insights, acquired ImPACT Concussion Management

synopsis: Riverside Insights, a provider of educational and clinical assessments and a portfolio company of Alpine Investors, has acquired ImPACT Applications, Inc., a leading provider of research-backed concussion assessments. ImPACT Applications offers the only FDA-cleared neurocognitive evaluation aid with concussion specific indications for ages 12-59.
buyer parent: Alpine Investors, LP
buyer: Riverside Insights
Riverside is a provider of educational and clinical assessments that play a key role in helping individuals elevate their learning potential by providing accurate and reliable data. Riverside is comprised of several iconic, leading brands such as Woodcock-Johnson, the Iowa Assessments, and CogAT. "
target: ImPACT Concussion Management
ImPACT Applications, Inc. is the maker of ImPACT, ImPACT Pediatric, and ImPACT Quick Test, all FDA cleared Class I & II medical devices and software solutions that assist in the screening, assessment, and management of concussion.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/27/2018 via PR Newswire

Elekta AB, acquired ACUMYN Inc.

synopsis: Elekta, the leading innovator of equipment and software used to improve and save lives, announced that it has acquired Acumyn, the Canadian quality assurance (QA) company. AQUA, Acumyn's Quality Management System, is a comprehensive software platform that coordinates and centralizes all of the QA tests needed.
buyer: Elekta AB (OM:EKTA B:$1,523.59)
Based in Sweden, Elekta AB is the leading innovator of equipment and software used to improve and save the lives of people with cancer and brain disorders. Elekta treatment solutions and oncology informatics are designed to enhance the delivery of treatment. "
target: ACUMYN Inc.
Acumyn, a medical technology company, created AQUA, a Quality Assurance software that ensures radiotherapy and medical imaging devices will perform reliably to deliver the best possible care to patients. Acumyn is known for their integrated Quality Management System, AQUA.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2017 via PR Web

BioClinica, Inc., acquired MDDX

synopsis: Bioclinica, a specialty clinical trials services and technology provider, has acquired MDDX, a developer of tools that have been used by researchers in dozens of global research trials. MDDX has created the most advanced cloud research image management platform that provides a private, searchable online image repository with a 20-year lifespan.
buyer parent: Cinven
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target: MDDX
MDDX has developed nearly a dozen tools that have been used by thousands of researchers in dozens of global research trials. The company has created the most advanced cloud research image management platform that provides a private, searchable online image repository with a 20-year lifespan.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/27/2016 via BNC Analysis

Venaxis, Inc., will acquire Strand Life Sciences

synopsis: Venaxis, a developer of an in vitro diagnostic test for acute appendicitis, is to acquire Strand Life Sciences, a cancer genomics firm. Strand's entry into healthcare was through software products and services that combine advanced visualization, systems modeling, and scientific insights for enabling biological and health sciences research.
buyer: Venaxis, Inc. (BIOP:$0.01)
Venaxis is a Colorado-based in vitro diagnostic company focused on developing and commercializing its unique multi-biomarker diagnostic test, the APPY1™ Test, which is designed to aid in the identification of patients at low risk for acute appendicitis. "
target: Strand Life Sciences
Strand's entry into healthcare was through software products and services that combine advanced visualization, systems modeling, and scientific insights for enabling biological and health sciences research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/27/2007 via BNC Analysis

Marine Park Holdings, Inc., merged with NewCardio, Inc.

synopsis: NewCardio, Inc. announced the closing of a share exchange agreement with Marine Park Holdings, Inc. whereby NewCardio is now a public company by way of reverse merger. NewCardio's common stock is currently quoted for trading on the Over the Counter Bulletin Board.
buyer: Marine Park Holdings, Inc.
Marine Park Holdings, Inc. formerly known as: EP Floors, Inc. does not have significant operations. "
target: NewCardio, Inc.
NewCardio is a Silicon Valley based company with the mission of fully developing and commercializing a three dimensional (3D) approach to electrocardiography.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2020 via BusinessWire

RapidAI, acquired Endovantage, LLC

synopsis: RapidAI, the worldwide leader in advanced imaging for stroke, announced the acquisition of EndoVantage, developer of the Find, Track and Treat™ comprehensive cerebral aneurysm management platform. EndoVantage provides clinicians with novel computational tools for the personalized planning of endovascular treatments.
buyer: RapidAI
RapidAI is the worldwide leader in advanced imaging for stroke. Installed in over 1,500 hospitals in more than 50 countries, the Rapid imaging platform, powered by artificial intelligence, includes Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS*. "
target: Endovantage, LLC
EndoVantage is the developer of the Find, Track and Treat™ comprehensive cerebral aneurysm management platform. EndoVantage provides clinicians with novel computational tools for the personalized planning of endovascular treatments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/29/2020 via Company Press Release

Ziehm Imaging, acquired THERENVA

synopsis: Germany-based Ziehm Imaging, a developer of mobile X-ray imaging solutions, has acquired Therenva, a leading French developer of planning and imaging software tools for cardiovascular procedures. Ziehm Imaging will leverage its strong distribution network of mobile C-arms to market Therenva’s current product portfolio globally.
buyer: Ziehm Imaging
Germany-based Ziehm Imaging specializes in the development, manufacturing, and worldwide marketing of mobile X-ray-based imaging solutions. The company is the recognized innovation leader in the mobile C-arm industry and a market leader in Germany and other European countries. "
target: THERENVA
France-based Therenva designs the most advanced and user-friendly imaging software toolset for cardiovascular procedures. The unique EndoSize 3D case planning software has become an essential tool in the daily practice of many physicians and healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/24/2017 via BNC Analysis

ERT, acquired ImageIQ

synopsis: ERT - a provider of clinical trial services - announced the acquisition of ImageIQ, an imaging software and contract research organization and software developer for customized imaging and analysis.
buyer parent: Nordic Capital
buyer: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions. "
target: ImageIQ
ImageIQ is an imaging software and contract research organization and software developer for customized imaging and analysis.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/24/2017 via BNC Analysis

ERT, acquired ImageIQ

synopsis: ERT - a provider of clinical trial services - announced the acquisition of ImageIQ, an imaging software and contract research organization and software developer for customized imaging and analysis.
buyer parent: Nordic Capital
buyer: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions. "
target: ImageIQ
ImageIQ is an imaging software and contract research organization and software developer for customized imaging and analysis.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/8/2016 via Company Press Release

ERT, acquired Exco InTouch, Ltd.

synopsis: ERT announced the acquisition of Exco InTouch, a leading provider of patient engagement, data capture and digital health solutions. The combined organization will provide the biopharmaceutical industry with the most advanced and comprehensive choice for electronic clinical outcome assessments (eCOA), patient engagement and digital health.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions. "
target: Exco InTouch, Ltd.
Exco InTouch is a leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers. Exco InTouch solutions provide simple, secure channels of communication; facilitating the collection of quality data and improving outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2016 via PR Newswire

Nordic Capital, will acquire ERT

synopsis: Genstar Capital, a leading private equity firm focused on the healthcare, software, financial services, and industrial technology industries, announced the sale of ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, to Nordic Capital Fund VIII.
buyer: Nordic Capital
Nordic Capital is a leader in Nordic private equity investments, and now has an enviable reputation in investment and portfolio management. Since launching in 1989, Nordic Capital funds have delivered outstanding returns for our investors. "
target parent: Genstar Capital LLC
target: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions.
price ($mm)
rev ($mm)
$300
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 2/27/2015 via PR Newswire

ERT, will acquire PHT Corporation

synopsis: ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, and PHT Corporation, the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced that they have signed a definitive agreement under which ERT will acquire PHT.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data. "
target parent: Boston Millennia Partners
target: PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2014 via Company Press Release

ERT, acquired eClinical Insights, Inc.

synopsis: ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, announced the acquisition of eClinical Insights (eCI), an innovative provider of cloud-based clinical trials management software.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data. "
target: eClinical Insights, Inc.
eClinical Insights® is a leading-edge provider of cloud-based clinical software that provides clinical research professionals with the strategic visibility to make rapid, data-driven decisions to positively impact the performance and cost of their clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/9/2012 via PR Newswire

ERT, acquired invivodata, Inc.

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations (CROs), announced the acquisition of invivodata, Inc, a leading provider of electronic Patient Reported Outcomes (ePRO) solutions and Consulting services, based in Pittsburgh, PA.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives. "
target: invivodata, Inc.
invivodata is a fully-integrated Clinical Outcome Assessments organization delivering regulatory-proven strategic consulting and practical electronic solutions to biopharmaceutical companies who depend upon patient-centered research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/3/2012 via PR Newswire

Genstar Capital LLC, acquired ERT

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations, announced that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction.
buyer: Genstar Capital LLC
Genstar Capital LLC has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, software and software services, insurance and financial services, and industrial technology industries. "
target: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives.
price ($mm)[EV]
$395 [$370]
rev ($mm)
$194
EBITDA ($mm)
$42
EV / rev
1.9x
EV / EBITDA
9.0x
closed 6/24/2009 via PR Newswire

OmniComm Systems, Inc., purchased EDC Solutions from eResearch Technology, Inc.

synopsis: OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, has acquired the EDC business of eResearchTechnology, Inc., a global provider of technology and services that enable life science industries worldwide to collect, interpret, and distribute cardiac safety and clinical data.
buyer: OmniComm Systems, Inc. (OTCPK:OMCM:$24.62)
OmniComm Systems, Inc. provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. "
seller: eResearch Technology, Inc.
eResearchTechnology, Inc. (eRT) is a provider of technology-based products and services that enable the pharmaceutical, biotechnological, medical device, and contract resource companies to collect, interpret, and distribute cardiac safety and clinical data more efficiently.
price ($mm)[EV]
$2.02 [$0.87]
rev ($mm)
$6
EBITDA ($mm)
EV / rev
0.1x
EV / EBITDA
announced 3/8/2016 via PR Newswire

Nordic Capital, will acquire ERT

synopsis: Genstar Capital, a leading private equity firm focused on the healthcare, software, financial services, and industrial technology industries, announced the sale of ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, to Nordic Capital Fund VIII.
buyer: Nordic Capital
Nordic Capital is a leader in Nordic private equity investments, and now has an enviable reputation in investment and portfolio management. Since launching in 1989, Nordic Capital funds have delivered outstanding returns for our investors. "
target parent: Genstar Capital LLC
target: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions.
price ($mm)
rev ($mm)
$300
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 7/3/2012 via PR Newswire

Genstar Capital LLC, acquired ERT

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations, announced that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction.
buyer: Genstar Capital LLC
Genstar Capital LLC has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, software and software services, insurance and financial services, and industrial technology industries. "
target: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives.
price ($mm)[EV]
$395 [$370]
rev ($mm)
$194
EBITDA ($mm)
$42
EV / rev
1.9x
EV / EBITDA
9.0x
closed 8/2/2004 via BusinessWire

Apogent Technologies, Inc. merged with Fisher Scientific International Inc.,

synopsis: Fisher Scientific International Inc. (NYSE: FSH) today completed its approximately $4.0 billion merger with Apogent Technologies Inc. (formerly trading as NYSE: AOT), providing Fisher Scientific with a $1.1 billion footprint in the high-growth life-science market.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Fisher Scientific International Inc.
Fisher Scientific International, Inc. provides products and services to the scientific research and clinical laboratory markets. It operates in three segments: Scientific Products and Services, Healthcare Products and Services, and Laboratory Workstations. The Scientific Products and Services segmen"
target: Apogent Technologies, Inc.
Apogent Technologies Inc. is a developer and manufacturer of value-added products for the clinical and research markets. Over 80% of the Company's products are consumables. Apogent's operating subsidiaries manufacture most of their products in approximately 80 facilities worldwide. The Company's cu
price ($mm)
$3,991
rev ($mm)
$1,118
EBITDA ($mm)
$313
EV / rev
3.6x
EV / EBITDA
12.7x
announced 1/22/2020 via PR Newswire

Clarivate Analytics, will acquire Decision Resources Group

synopsis: Clarivate Analytics plc, a global leader in providing trusted insights and analytics, will acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group.
buyer: Clarivate Analytics (:$964.58)
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management. "
target parent: Piramal Group
target: Decision Resources Group
Decision Resources Group (DRG) is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access.
price ($mm)
$950
rev ($mm)
$207
EBITDA ($mm)
$48
EV / rev
4.6x
EV / EBITDA
20.0x
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
announced 1/13/2020 via GlobeNewswire

TelaDoc, Inc., will acquire InTouch Health

synopsis: Teladoc Health, Inc., the global leader in virtual care, will acquire InTouch Health, the leading provider of enterprise telehealth solutions for hospitals and health systems. This acquisition positions Teladoc Health as the partner of choice for health systems seeking a single solution for their entire virtual care strategy.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc Health is transforming the healthcare experience with a focus on high quality, lower costs, and improved outcomes. Telehealth Satisfaction Study, the integrated services from Teladoc Health include telehealth, expert medical services, AI and analytics, and licensable platform services. "
target parent: Galen Partners
target: InTouch Health
InTouch Health is a telehealth services company that offers healthcare providers a reliable, dedicated cloud-based network and virtual care solutions to efficiently deliver care for a broad array of use cases and healthcare environments.
price ($mm)
$600
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/27/2009 via Reuters

The Carlyle Group, will acquire Broadleaf Co., Ltd.

synopsis: Private equity firm The Carlyle Group announced that it has agreed to purchase Broadleaf Co, a Japanese maker of software for car maintenance facilities. This is the first buyout for Carlyle in Japan since it bought LCD glass maker AvanStrate Inc.
buyer: The Carlyle Group (CG:$1,614.20)
The Carlyle Group is a private global investment firm that originates, structures and acts as lead equity investor in management-led buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. "
target parent: Olympus Corporation
target: Broadleaf Co., Ltd.
Broadleaf Co. is involved in the development, sale, and support of various software packages for the automotive industry, including the Super Frontman automobile maintenance system, administrative system packages for inventory control, customer control, and estimate/sales/billing control.
price ($mm)
$212
rev ($mm)
$181
EBITDA ($mm)
EV / rev
1.2x
EV / EBITDA
closed 12/11/2019 via PR Newswire

Corrona, Inc., acquired HealthiVibe LLC

synopsis: Corrona, LLC, a leading provider of real-world observational and syndicated registry data, announced that it has acquired HealthiVibe, LLC, a leading patient experience company. HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives of the product lifecycle.
buyer parent: Great Point Partners
buyer: Corrona, Inc.
Corrona provides real world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. "
target: HealthiVibe LLC
HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives of the product lifecycle. They leverage models and online analytic platforms to provide tools to optimize clinical trials and enhance product commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/22/2016 via PR Newswire

The WIRB-Copernicus Group, acquired CenterWatch, Inc.

synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information. CenterWatch provides clinical trials information to clinical research professionals.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
target: CenterWatch, Inc.
CenterWatch is the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from sponsors and CROs, to investigative sites, technology solutions and niche providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/5/2010 via Company Press Release

Kenneth Getz, acquired CenterWatch, Inc.

synopsis: Ken Getz, the founder of CenterWatch—an industry-leading clinical trials information services company—along with private equity investors has purchased the company from Jobson Medical Information.
buyer: Kenneth Getz
Ken Getz founded CenterWatch in 1994 and established the company as a leading provider of operating and business information on the $40 billion global clinical trials industry. Getz sold the company to the Thomson Corporation in 1998. "
target parent: Wicks Group of Companies
target: CenterWatch, Inc.
CenterWatch is a trusted source and global destination of clinical trials information for both professionals and patients. CenterWatch provides a wide variety of information services including grant leads for investigative sites, data about the global clinical trials industry and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/31/2007 via Berkery

Jobson Medical Information LLC, acquired CenterWatch, Inc.

synopsis: The Thomson Corporation announced the sale of CenterWatch to Jobson Medical Information, a portfolio company of The Wicks Group, LLC. CenterWatch is a trusted source and global leader in providing proprietary data and information about clinical trials to both professionals and patients.
buyer parent: The Wicks Group of Companies, L.L.C.
buyer: Jobson Medical Information LLC
Jobson Medical Information is a leading specialty healthcare communications, publishing, and medical education company. Jobson Medical Information produces a broad range of publications, educational programs, enduring educational materials, live events, symposia and websites. "
target parent: Thomson Corporation
target: CenterWatch, Inc.
CenterWatch is a trusted source and global leader in providing proprietary data and information about clinical trials to both professionals and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/9/2019 via BNC Analysis

Genstar Capital LLC, acquired Advarra

synopsis: Genstar Capital, a private equity firm focused on investments in financial services, healthcare, industrial technology, and software industries, has acquired Advarra, a leading provider of institutional review board, institutional biosafety committee, and research quality and compliance solutions that are critical to the drug development process.
buyer: Genstar Capital LLC
Genstar Capital is a leading private equity firm that actively invests in high quality companies. Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. "
target parent: Linden Capital Partners
target: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/26/2020 via PR Newswire

Arsenal Capital Partners, acquired BresMed Health Solutions Ltd

synopsis: Arsenal Capital Partners, a leading private equity firm investing in healthcare and specialty industrials companies, announced the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.
buyer: Arsenal Capital Partners
Arsenal is a leading private equity firm that specializes in investments in middle‐market specialty industrials and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of $5.3 billion, and completed more than 45 platform investments. "
target: BresMed Health Solutions Ltd
BresMed is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry. Established in 2006, BresMed has more than 150 staff across offices in the U.K., Ireland, the Netherlands, the U.S., and India.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/16/2017 via PR Newswire

Decision Resources Group, acquired Context Matters

synopsis: Decision Resources Group announced that it has completed the acquisition of Context Matters, the innovative data technology start-up that developed a first-of-its-kind global market access integrated data platform.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
target: Context Matters
Context Matters is led by a team with extensive experience in the pharma & biotech and financial & information sectors with deep operational familiarity of the issues facing the pharmaceutical industry and those following the industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/5/2020 via GlobeNewswire

Livongo will be merged with TelaDoc, Inc.,

synopsis: Teladoc Health, the global leader in virtual care, and Livongo, the leading Applied Health Signals company, have entered into a definitive merger agreement. The combination of Teladoc Health and Livongo will create a global leader in consumer centered virtual care. The combined company will operate under the Teladoc Health brand.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc Health is recognized as the world leader in virtual care. They deliver millions of medical visits across 175 countries annually through the Teladoc Health Medical Group, enabling millions of patient and provider touchpoints for hospitals, health systems, and physician practices globally. "
target: Livongo (LVGO:$257.96)
Livongo empowers people with chronic conditions to live better and healthier lives. Using its AI+AI engine, Livongo aggregates and interprets health data and information to create actionable, personalized, and timely health signals delivered to Livongo Members exactly when and where they need them.
price ($mm)[EV]
$16,988 [$16,567]
rev ($mm)
$258
EBITDA ($mm)
EV / rev
70.8x
EV / EBITDA
announced 6/3/2020 via BusinessWire

BreathResearch will be merged with AireHealth,

synopsis: AireHealth Inc., a company that offers affordable treatments, symptom tracking and early detection of respiratory conditions, has reached a merger agreement with BreathResearch, a respiratory healthcare company that detects increasing declines in respiratory health status.
buyer: AireHealth
AireHealth offers affordable treatments, symptom tracking and early detection of respiratory conditions. The company provides monitored drug delivery via its FDA cleared Class 2 portable nebulizer, designed to deliver medicine directly to a patient’s lungs where it is most effective. "
target: BreathResearch
BreathResearch is an innovative healthcare company that offers a solution that converts the air waves from breathing into sound waves producing new respiratory analytics to improve health, fitness and performance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/16/2009 via PR Newswire

Water Street Healthcare Partners, acquired AAIPharma Services

synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer: Water Street Healthcare Partners
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent: AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/22/2005 via BNC Analysis

Clinical Data, Inc., will acquire Genaissance Pharmaceuticals, Inc.

synopsis: Clinical Data Inc. announced Tuesday that it will acquire Genaissance Pharmaceuticals in an all-stock transaction valued at $56 million. Genaissance shareholders will own 40 percent of the combined company when the deal closes sometime in the fourth quarter.
buyer: Clinical Data, Inc. (CLDA:$0.00)
Clinical Data, Inc. provides a full range of products and services to the growing domestic Physician Office Laboratory market and to smaller laboratories internationally & also provides a complete range of products and services for the Physician Office Laboratory and hospital laboratory market. "
target: Genaissance Pharmaceuticals, Inc.
Genaissance is a world leader in the discovery and use of human gene variation for the development of a new generation of DNA-based diagnostic and therapeutic products. Genaissance markets its technology, clinical development skills and Pharmacogenomic support services to the pharmaceutical industr
price ($mm)
$56
rev ($mm)
$21
EBITDA ($mm)
EV / rev
2.7x
EV / EBITDA
closed 1/9/2020 via BusinessWire

Riverside Insights, acquired ImPACT Concussion Management

synopsis: Riverside Insights, a provider of educational and clinical assessments and a portfolio company of Alpine Investors, has acquired ImPACT Applications, Inc., a leading provider of research-backed concussion assessments. ImPACT Applications offers the only FDA-cleared neurocognitive evaluation aid with concussion specific indications for ages 12-59.
buyer parent: Alpine Investors, LP
buyer: Riverside Insights
Riverside is a provider of educational and clinical assessments that play a key role in helping individuals elevate their learning potential by providing accurate and reliable data. Riverside is comprised of several iconic, leading brands such as Woodcock-Johnson, the Iowa Assessments, and CogAT. "
target: ImPACT Concussion Management
ImPACT Applications, Inc. is the maker of ImPACT, ImPACT Pediatric, and ImPACT Quick Test, all FDA cleared Class I & II medical devices and software solutions that assist in the screening, assessment, and management of concussion.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like ImageIQ


read more

ImageIQ

Invicro, LLC

Object Research Systems, Inc.

Skope Magnetic Resonance Technologies AG

Imaging Biometrics

Clinical Graphics, B.V.

RxEye AB

Morphormics, Inc.

Lifecode, Inc.

imorphics

Telemis

Heart IT

Amira

ImPACT Concussion Management

ACUMYN Inc.

MDDX

Strand Life Sciences

NewCardio, Inc.

Endovantage, LLC

THERENVA

read more

ImageIQ

read more

ImageIQ

Exco InTouch, Ltd.

ERT

PHT Corporation

eClinical Insights, Inc.

invivodata, Inc.

ERT

eResearch Technology, Inc.

read more

ERT

ERT

Apogent Technologies, Inc.

Decision Resources Group

Abacus International

Decision Resources Group

InTouch Health

Broadleaf Co., Ltd.

HealthiVibe LLC

CenterWatch, Inc.

CenterWatch, Inc.

CenterWatch, Inc.

Advarra

BresMed Health Solutions Ltd

Context Matters

Livongo

BreathResearch

AAIPharma Services

Genaissance Pharmaceuticals, Inc.

ImPACT Concussion Management

Geography
Matching Companies
Ticker: STO:SECTB
 
 
 
 
 
 
 
 
Sectra AB
Sectra AB
Sectra successfully develops and sells cutting edge solutions and services within the niches medical IT and secure communication. The company’s products are used by customers in 50 countries and sales are conducted directly by Sectra as well as through regional partners.
year
2015
rev ($mm)
$121.11
EBITDA ($mm)
$19.82
EBIT ($mm)
$16.26
Net Income ($mm)
$13.69
Employees
603
  • drill down
  • watch
Ticker: LH
 
 
 
 
 
 
 
 
LabCorp
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp processes tests on approximately 470,000 specimens each day, applying advances in medicine and science to laboratory testing.
year
2009
rev ($mm)
$4,694.70
EBITDA ($mm)
$1,142.70
EBIT ($mm)
$949.40
Net Income ($mm)
$543.30
Employees
28000
  • drill down
  • watch
Ticker: GS:MTLS
 
 
 
 
 
 
 
 
Materialise Dental N.V.
Materialise Dental N.V.
Materialise Dental offers planning and simulation software tools under the SimPlant brand. These tools enable implantologists and oral surgeons to scientifically plan dental implant surgery on an interactive basis.
year
2014
rev ($mm)
$86.16
EBITDA ($mm)
$5.18
EBIT ($mm)
$0.35
Net Income ($mm)
$2.18
Employees
958
  • drill down
  • watch
Ticker: CERN
 
 
 
 
 
 
 
 
Cerner Corporation
Cerner Corporation
Cerner's health information technologies connect people, information, and systems. Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations.
year
2020
rev ($mm)
$5,714.46
EBITDA ($mm)
$1,168.86
EBIT ($mm)
$707.10
Net Income ($mm)
$510.39
Employees
27400
  • drill down
  • watch
Ticker: 300253
 
 
 
 
 
 
 
 
Shanghai Kingstar Winning Software Co., Ltd.
Shanghai Kingstar Winning Software is principally engaged in the development of medical software, the provision of technology services and the distribution of hardware products. They primarily offer software, including hospital information systems and public health information management systems.
year
2015
rev ($mm)
$98.42
EBITDA ($mm)
$14.01
EBIT ($mm)
$12.72
Net Income ($mm)
$21.57
Employees
454
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: MDRX
 
 
 
 
 
 
 
 
Allscripts
Allscripts
Allscripts is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The company's unique solutions inform, connect and transform healthcare, delivering improved care at lower cost.
year
2020
rev ($mm)
$1,718.10
EBITDA ($mm)
$70.02
EBIT ($mm)
($3.04)
Net Income ($mm)
Employees
9600
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2020
rev ($mm)
$906.40
EBITDA ($mm)
$100.91
EBIT ($mm)
$61.95
Net Income ($mm)
$49.09
Employees
2780
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2019
rev ($mm)
$879.35
EBITDA ($mm)
$200.48
EBIT ($mm)
$134.28
Net Income ($mm)
$82.69
Employees
5171
  • drill down
  • watch
Ticker: QSII
 
 
 
 
 
 
 
 
Quality Systems, Inc.
Quality Systems, Inc.
Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices.
year
2015
rev ($mm)
$499.35
EBITDA ($mm)
$57.19
EBIT ($mm)
$44.23
Net Income ($mm)
$32.10
Employees
2927
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: QHR
 
 
 
 
 
 
 
 
QHR Technologies Inc.
QHR Technologies Inc.
QHR is a leader in Healthcare Technology, empowering providers and connecting patients. With an 11-year track record offering what is now the single leading Electronic Medical Records in Canada, QHR has a suite of complementary offerings that empower health professionals.
year
2016
rev ($mm)
$23.60
EBITDA ($mm)
$2.08
EBIT ($mm)
$0.83
Net Income ($mm)
$0.09
Employees
200
  • drill down
  • watch
Ticker: ENXTPA:DIM
 
 
 
 
 
 
 
 
Sartorius AG
Sartorius AG
Sartorius is a international pharmaceutical and laboratory equipment supplier. With their innovative products and services, they are helping their customers across the entire globe to implement their complex and quality-critical biomanufacturing and laboratory processes reliably and economically.
year
2016
rev ($mm)
$1,121.72
EBITDA ($mm)
$299.20
EBIT ($mm)
$257.20
Net Income ($mm)
$163.92
Employees
4590
  • drill down
  • watch
Ticker: ENXTPA:BIM
 
 
 
 
 
 
 
 
bioMérieux S.A.
bioMérieux S.A.
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety.
year
2015
rev ($mm)
$1,996.55
EBITDA ($mm)
$404.73
EBIT ($mm)
$278.41
Net Income ($mm)
$155.44
Employees
9258
  • drill down
  • watch
Ticker: XTRA:SBS
 
 
 
 
 
 
 
 
Stratec SE
Stratec SE
STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers complex consumables for diagnostic and medical applications.
year
2019
rev ($mm)
$240.89
EBITDA ($mm)
$38.57
EBIT ($mm)
$21.94
Net Income ($mm)
$15.69
Employees
1223
  • drill down
  • watch
Ticker: ABT
 
 
 
 
 
 
 
 
Abbott Laboratories
Abbott Laboratories
Abbott Laboratories is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.
year
2009
rev ($mm)
$30,764.71
EBITDA ($mm)
$8,220.25
EBIT ($mm)
$6,130.74
Net Income ($mm)
$5,745.84
Employees
73000
  • drill down
  • watch
Ticker: BDX
 
 
 
 
 
 
 
 
Becton, Dickinson and Company
Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is a leading medical technology company. BD’s innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research.
year
2012
rev ($mm)
$7,708.38
EBITDA ($mm)
$1,970.62
EBIT ($mm)
$1,577.89
Net Income ($mm)
$1,169.93
Employees
  • drill down
  • watch
Ticker: SYK
 
 
 
 
 
 
 
 
Stryker Corporation
Stryker Corporation
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties.
year
2016
rev ($mm)
$10,062.00
EBITDA ($mm)
$2,717.00
EBIT ($mm)
$2,312.00
Net Income ($mm)
$1,617.00
Employees
27000
  • drill down
  • watch
Ticker: CAH
 
 
 
 
 
 
 
 
Cardinal Health, Inc.
Cardinal Health, Inc.
Cardinal Health, Inc. improves the cost-effectiveness of the health care industry. Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability.
year
2018
rev ($mm)
$141,935.00
EBITDA ($mm)
$2,870.00
EBIT ($mm)
$1,860.00
Net Income ($mm)
Employees
50200
  • drill down
  • watch
Ticker: FMS
 
 
 
 
 
 
 
 
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA
As a vertically integrated company, we offer products and services for the entire dialysis value chain. The highest medical standards are our benchmark.
year
2009
rev ($mm)
$11,247.48
EBITDA ($mm)
$2,212.68
EBIT ($mm)
$1,755.60
Net Income ($mm)
$891.14
Employees
72812
  • drill down
  • watch
Ticker: COV
 
 
 
 
 
 
 
 
Covidien
Covidien
Tyco Healthcare became Covidien and began independently trading on the New York and Bermuda Stock Exchanges on July 2, 2007, marking its debut as an independent diversified global healthcare products company.
year
2010
rev ($mm)
$10,429.00
EBITDA ($mm)
$2,628.00
EBIT ($mm)
$2,139.00
Net Income ($mm)
$1,632.00
Employees
41500
  • drill down
  • watch
Ticker: FAGR
 
 
 
 
 
 
 
 
Fagron
Fagron
Fagron is an innovative scientific pharmaceutical R&D company that is focused on optimising and innovating pharmaceutical compounding worldwide. Fagron offers Fagron Compounding Essentials, Fagron Trademarks and Fagron Compounding Services to pharmacies and hospital pharmacies in 30 countries.
year
2014
rev ($mm)
$473.30
EBITDA ($mm)
$113.50
EBIT ($mm)
$96.32
Net Income ($mm)
$17.17
Employees
1902
  • drill down
  • watch
Ticker: SPA
 
 
 
 
 
 
 
 
Sparton Corporation
Sparton Corporation
Sparton Corporation, now in its 115th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service, and refurbishment.
year
2014
rev ($mm)
$338.86
EBITDA ($mm)
$32.07
EBIT ($mm)
$23.21
Net Income ($mm)
$10.89
Employees
1385
  • drill down
  • watch
Ticker: SGN
 
 
 
 
 
 
 
 
Signalife, Inc.
Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring.
year
2007
rev ($mm)
EBITDA ($mm)
($14.36)
EBIT ($mm)
($14.46)
Net Income ($mm)
Employees
15
  • drill down
  • watch
Ticker: HAE
 
 
 
 
 
 
 
 
Haemonetics Corporation
Haemonetics Corporation
Haemonetics is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions. Their technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.
year
2020
rev ($mm)
$988.48
EBITDA ($mm)
$266.02
EBIT ($mm)
$173.83
Net Income ($mm)
$76.53
Employees
3004
  • drill down
  • watch
Ticker: BABY
 
 
 
 
 
 
 
 
Natus Medical, Incorporated
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment and neurological dysfunction.
year
2014
rev ($mm)
$352.46
EBITDA ($mm)
$64.99
EBIT ($mm)
$54.44
Net Income ($mm)
$30.91
Employees
943
  • drill down
  • watch
Ticker: MDT
 
 
 
 
 
 
 
 
Medtronic, Inc.
Medtronic, Inc.
Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions.
year
2020
rev ($mm)
$31,062.00
EBITDA ($mm)
$9,558.00
EBIT ($mm)
$7,097.00
Net Income ($mm)
$5,408.00
Employees
90000
  • drill down
  • watch